The Duke-Robert J. Margolis Institute for Health Policy has introduced the ‘International Harmonization of RWE Standards Dashboard,’ a tool designed to synchronize real-world data and evidence (RWD/E) standards across global regulators. This initiative underscores the collective effort to streamline RWE standards, facilitating more coherent regulatory submissions worldwide.
Development and Methodology
To construct the dashboard, the institute gathered guidance documents, both draft and final, from medical product regulators around the globe. These documents were translated into English by certified translators when necessary. Expert consultations played a pivotal role in collating and interpreting the information, ensuring that the dashboard accurately reflects the current regulatory landscape.
Key Definitions and Standards
The dashboard focuses on three critical terms: relevance, reliability, and quality. These terms are essential for describing fit-for-use RWE in regulatory submissions. By standardizing these definitions, the dashboard aims to enhance the consistency and comparability of RWD/E used in various regulatory contexts.
• Data representativeness ensures that research findings are applicable to broader populations.
• Accuracy in data interpretation reinforces the reliability of study outcomes.
• Quality assurance across sites maintains the integrity of data over time.
As of February 2025, the U.S. Food and Drug Administration (FDA) leads with 13 RWE guidance documents, including four drafts and nine final versions. Additionally, the European Medicines Agency (EMA), Taiwan FDA, and Brazil’s ANVISA have each defined at least two of the key terms, signaling a growing alignment among major regulatory bodies.
The analysis reveals areas where definitions align, such as data representativeness and quality assurance. However, discrepancies remain in clinical context and data availability, highlighting the need for further harmonization to address these misalignments effectively.
By identifying both aligned and misaligned areas, the dashboard provides a clear roadmap for regulators to achieve greater consistency. This alignment is crucial for improving the reliability and applicability of real-world evidence in regulatory decision-making.
Facilitating global harmonization of RWE standards not only enhances regulatory processes but also fosters international collaboration. Stakeholders can leverage the dashboard to navigate the complexities of RWD/E standards, ultimately leading to more informed and efficient healthcare policies.
The introduction of the ‘International Harmonization of RWE Standards Dashboard’ marks a significant step towards unifying real-world data standards. By addressing both alignment and misalignment issues, the tool provides valuable insights for regulators aiming to standardize RWE, thereby improving the overall quality and impact of real-world evidence in shaping health policies.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
